Loading market dashboard

Financials in USD. Standardized financial statements.
A compact view of how Entera Bio Ltd. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $42,000 | $181,000 | $0 | $134,000 | $571,000 | $365,000 | $236,000 | $500,000 | $0 | $0 |
| Revenue Growth? | -76.8% | 0.0% | -100.0% | -76.5% | +56.4% | +54.7% | -52.8% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $42,000 | $172,000 | $56,000 | $165,000 | $373,000 | $300,000 | $448,000 | $0 | $43,000 | $35,000 |
| Gross Profit? | $0 | $9,000 | -$56,000 | -$31,000 | $198,000 | $65,000 | -$212,000 | $500,000 | -$43,000 | -$35,000 |
| Gross Margin? | 0.0% | +5.0% | 0.0% | -23.1% | +34.7% | +17.8% | -89.8% | +100.0% | 0.0% | 0.0% |
| Operating Expenses? | $11.53M | $9.59M | $8.88M | $13.04M | $12.41M | $11.23M | $11.24M | $11.36M | $11.34M | $5.37M |
| Operating Income? | -$11.53M | -$9.59M | -$8.94M | -$13.07M | -$12.22M | -$11.17M | -$11.45M | -$10.86M | $11.34M | -$5.37M |
| EBITDA? | -$11.50M | -$9.54M | -$8.80M | -$12.87M | -$12.16M | -$11.11M | -$10.47M | -$10.81M | -$11.05M | -$5.33M |
| Income Before Tax | -$11.44M | -$9.53M | -$8.86M | -$12.93M | -$12.25M | -$11.20M | -$10.79M | -$10.30M | -$11.20M | -$1.20M |
| Income Tax Expense | $0 | $14,000 | $29,000 | $137,000 | -$59,000 | $20,000 | $0 | $0 | -$146,000 | $0 |
| Net Income? | -$11.44M | -$9.54M | -$8.89M | -$13.07M | -$12.19M | -$11.22M | -$10.79M | -$10.30M | -$11.20M | -$1.20M |
| EPS? | $-0.25 | $-0.25 | $-0.31 | $-0.45 | $-0.47 | $-0.54 | $-0.90 | $-0.91 | $-1.31 | $-0.14 |
| Diluted EPS? | $-0.25 | $-0.25 | $-0.31 | $-0.45 | $-0.47 | $-0.54 | $-0.90 | $-1.29 | $-0.94 | $-0.10 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality